FDA approval of a generic fidaxomicin formulation; regulatory action does not itself establish clinical efficacy or comparative benefit.
Reported
Approved strength200 mg
Approval date2026-08-13
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of a generic fidaxomicin formulation; regulatory action does not itself establish clinical efficacy or comparative benefit.